Trial intelligence / Profile preview

Bioequivalence study of citalopram tablets in healthy Chinese adults

ChiCTR-TRC-11001533Phase 4Completed

Sponsor
Henan Provincial People's Hospital
Start
May 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of citalopram in major depressive disorder (MDD) (3 arms), sponsored by Henan Provincial People's Hospital. Primary endpoint: Pharmacokinetic parameters. Started May 2011; status: completed.

02

Drugs

citalopram
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on ChiCTR-TRC-11001533.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-11001533.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call